Innovative tests for
cancer patient monitoring

Discover our new M*Detect product for digital PCR !

MDetect kits from METHYS Dx are based on proprietary methylation signatures and are compatible with commercially available digital PCR instruments. MDetect kits are used to analyze circulating tumor DNA from patients with advanced cancers (stages III–IV). Thanks to the use of digital PCR, results can be obtained within a single day.

kits_methysdx_biopsieliquide
Prélèvement dans une éprouvette

Based on
methylated dna biomarkers

Our tests are based on liquid biopsies, and target the analysis of certain types of biomarkers, present in biological fluids, such as blood. METHYS Dx develops panels of methylation markers, in order to characterize circulating tumor DNA (ctDNA) within liquid biopsies. The tests developped by METHYS Dx will thus be used to establish prognosis, monitor tumor evolution, and allow the early detection of relapses.

The tests developped by METHYS Dx target different cancer types, amongst the most frequent. These tests are based on a novel detection technology, and present an efficient and less-costly alternative to NGS tests. METHYS Dx tests can also be used for quality control of results obtained using other technologies (NGS or digital PCR for example).

METHYS Dx

Our values

Scientifique dans son laboratoire
Innovation

Innovation

Précision

Precision & Reliability

Bienveillance

Passion

news

06Oct FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology

The Fédération Francophone de Cancérologie Digestive (FFCD) and METHYS Dx have decided to combine their expertise to contribute to the development of new approaches aimed at improving the monitoring of patients with digestive cancers. This partnership reflects a shared ambition: to advance clinical research and foster the emergence of innovative tools to support increasingly personalized […]

> Know more
18Jun METHYS Dx, winner of Business O Féminin Award

✨ A memorable VivaTech for METHYS Dx! We were honored to see Valerie Taly be awarded a Business O Féminin Award on Thursday, June 18th 🏆, a meaningful recognition of her commitment to driving innovation in healthcare. 👏Congratulations as well to the other award recipients : Manel Chikh – My Bubble Health, Sandra Kamdeu – […]

> Know more